Category
Today's News
More News
Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with

Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with
FDA approves CAR T cell treatment for resistant mantle cell lymphoma

FDA approves CAR T cell treatment for resistant mantle cell lymphoma

by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme

FDA approves CAR T cell treatment for resistant mantle cell lymphoma

by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
Measuring 'quality of life' is an important trend in cancer care

Measuring 'quality of life' is an important trend in cancer care

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit

Measuring 'quality of life' is an important trend in cancer care

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
New AI tool predicts risk for chronic pain in cancer patients

New AI tool predicts risk for chronic pain in cancer patients

by Eric Hamilton,University of FloridaOverview of our transformer-based chronic pain prediction model: Three different data inputs are passed into dedicated encoders to generate a final vector t

New AI tool predicts risk for chronic pain in cancer patients

by Eric Hamilton,University of FloridaOverview of our transformer-based chronic pain prediction model: Three different data inputs are passed into dedicated encoders to generate a final vector t
Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer
Study examines trends in esophageal cancer disparities over time

Study examines trends in esophageal cancer disparities over time

by Elana GotkineFrom 1999 to 2020, age-adjusted esophageal cancer mortality decreased among Black adults but stabilized among white adults, reducing the racial mortality gap, according to a study&nbsp

Study examines trends in esophageal cancer disparities over time

by Elana GotkineFrom 1999 to 2020, age-adjusted esophageal cancer mortality decreased among Black adults but stabilized among white adults, reducing the racial mortality gap, according to a study&nbsp
Treatment for recurrent uterine cancer advances to next research phase

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc
Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr
Early menopause appears raise odds of breast cancer, study reports

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear
Week’s Top
Podcasts
... Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine... ... AlphaFold: The making of a scientific breakthrough The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p... ... Announcement of the 2024 Nobel Prize in Chemistry The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was...